KR158 Spheres Harboring Slow-Cycling Cells Recapitulate High-Grade Glioma Features in an Immunocompetent System
Cells · 2024
DOI: 10.3390/cells13110938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Avirup Chakraborty und 14 weiteren Autor:innen. Beteiligte Einrichtung: Adam Michael Rosen Neuro-Oncology Laboratories, Department of Neurosurgery, University of Florida, Gainesville, FL 32608, USA. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Spheroids, Cellular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health, NCI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Glioblastoma (GBM) poses a significant challenge in clinical oncology due to its aggressive nature, heterogeneity, and resistance to therapies. Cancer stem cells (CSCs) play a critical role in GBM, particularly in treatment resistance and tumor relapse, emphasizing the need to comprehend the mechanisms regulating these cells. Also, their multifaceted contributions to the tumor microenvironment (TME) underline their significance, driven by their unique properties. This study aimed to characterize glioblastoma stem cells (GSCs), specifically slow-cycling cells (SCCs), in an immunocompetent murine GBM model to explore their similarities with their human counterparts. Using the KR158 mouse model, we confirmed that SCCs isolated from this model exhibited key traits and functional properties akin to human SCCs. KR158 murine SCCs, expanded in the gliomasphere assay, demonstrated sphere forming ability, self-renewing capacity, positive tumorigenicity, enhanced stemness and resistance to chemotherapy. Together, our findings validate the KR158 murine model as a framework to investigate GSCs and SCCs in GBM pathology, and explore specifically the SCC–immune system communications, understand their role in disease progression, and evaluate the effect of therapeutic strategies targeting these specific connections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Adam Michael Rosen Neuro-Oncology Laboratories, Department of Neurosurgery, University of Florida, Gainesville, FL 32608, USA.
- Preston A. Wells Jr. Center for Brain Tumor Therapy, University of Florida, Gainesville, FL 32608, USA.
- Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA.
- Department of Surgery, University of Florida, Gainesville, FL 32610, USA.
- College of Dental Medicine, Nova Southeastern University, Fort Lauderdale, FL 33314, USA.
- Department of Pharmacology and Therapeutics, University of Florida, Gainesville, FL 32603, USA.
ORCID-Profile: Avirup Chakraborty, Changlin Yang, Jesse L Kresak, Aryeh J Silver, Loic P Deleyrolle
Förderung
- National Institute of Health
- NCI NIH HHS
- NINDS NIH HHS
Zitieren
APA
Chakraborty, A., Yang, C., Kresak, J. L., Silver, A. J., Feier, D., Tian, G., Andrews, M., Sobanjo, O. O., Hodge, E. D., Engelbart, M. K., Huang, J., Harrison, J. K., Sarkisian, M. R., Mitchell, D. A., & Deleyrolle, L. P. (2024). KR158 Spheres Harboring Slow-Cycling Cells Recapitulate High-Grade Glioma Features in an Immunocompetent System. Cells. https://doi.org/10.3390/cells13110938
Vancouver
Chakraborty A, Yang C, Kresak JL, Silver AJ, Feier D, Tian G, et al. KR158 Spheres Harboring Slow-Cycling Cells Recapitulate High-Grade Glioma Features in an Immunocompetent System. Cells. 2024. doi:10.3390/cells13110938
BibTeX
@article{Chakraborty2024,
author = {Chakraborty, Avirup and Yang, Changlin and Kresak, Jesse L and Silver, Aryeh J and Feier, Diana and Tian, Guimei and Andrews, Michael and Sobanjo, Olusegun O and Hodge, Ethan D and Engelbart, Mia K and Huang, Jianping and Harrison, Jeffrey K and Sarkisian, Matthew R and Mitchell, Duane A and Deleyrolle, Loic P},
title = {KR158 Spheres Harboring Slow-Cycling Cells Recapitulate High-Grade Glioma Features in an Immunocompetent System},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13110938}
}
EUVIMED